HomeFilePharmacology

Pharmacology

View Category

Antiplatelet

Does Ticagrelor Reduce Events in Peripheral Artery Disease?

Original Title: Ticagrelor for Prevention of Ischemic Events after Myocardial Infarction in Patients with Peripheral Artery Disease. Reference:...
solaci -
Learn More
Acute coronary syndromes

Metoprolol before primary PCI doesn’t reduce infarction size

Original Title: Early Intravenous Beta-Blockers in Patients with ST-Segment Elevation Myocardial Infarction before Primary Percutaneous Coronary Intervention. Reference:...
solaci -
Learn More
Antiplatelet

STEMI: Best P2Y12 inhibitor according to network meta-analysis

Original Title: Optimal P2Y12 inhibitor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention:...
solaci -
Learn More
Antiplatelet

Effects of switching from prasugrel to ticagrelor in patients with ACS

Original Title: Pharmacodynamic Effects of Switching from Prasugrel to Ticagrelor Results of the Prospective, Randomized SWAP-3 Study Reference:...
solaci -
Learn More
Acute coronary syndromes

Optimal Duration of Dual Antiplatelet Therapy: New ACC-AHA Guidelines

Original Title: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary...
solaci -
Learn More
Antithrombotic Anticoagulants

Vorapaxar in Acute Limb Ischemia

Original Title: Acute Limb Ischemia and Outcomes With Vorapaxar in Patients with Peripheral Artery Disease: Results From...
solaci -
Learn More
Antithrombotic Anticoagulants

Bivalirudin could be beneficial in peripheral PCI

Original Title: Bivalirudin Is Associated with Improved In-Hospital Outcomes Compared with Heparin in Percutaneous Vascular Intervention. Observational,...
solaci -
Learn More
Antiplatelet

Ticagrelor vs Clopidogrel in low risk coronary syndrome

Original Title: Effects of Ticagrelor versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI. Reference:...
solaci -
Learn More